nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—IL1B—systemic scleroderma	0.725	1	CbGaD
Gallium nitrate—BGLAP—forelimb zeugopod—systemic scleroderma	0.0208	0.195	CbGeAlD
Gallium nitrate—BGLAP—skeletal joint—systemic scleroderma	0.0138	0.129	CbGeAlD
Gallium nitrate—IL1B—dermis—systemic scleroderma	0.0137	0.128	CbGeAlD
Gallium nitrate—IL1B—skeletal joint—systemic scleroderma	0.0118	0.11	CbGeAlD
Gallium nitrate—IL1B—artery—systemic scleroderma	0.00494	0.0462	CbGeAlD
Gallium nitrate—Edema of lower extremities—Mycophenolic acid—systemic scleroderma	0.00443	0.0616	CcSEcCtD
Gallium nitrate—IL1B—Interleukin-1 processing—IL1A—systemic scleroderma	0.00441	0.0482	CbGpPWpGaD
Gallium nitrate—IL1B—endothelium—systemic scleroderma	0.00417	0.039	CbGeAlD
Gallium nitrate—IL1B—blood vessel—systemic scleroderma	0.00385	0.036	CbGeAlD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.00346	0.0378	CbGpPWpGaD
Gallium nitrate—TF—blood vessel—systemic scleroderma	0.00343	0.0321	CbGeAlD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—CSF1—systemic scleroderma	0.00305	0.0333	CbGpPWpGaD
Gallium nitrate—Rales—Captopril—systemic scleroderma	0.00276	0.0383	CcSEcCtD
Gallium nitrate—IL1B—IFN-gamma pathway—SMAD7—systemic scleroderma	0.00263	0.0287	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—CSF1—systemic scleroderma	0.00248	0.0271	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—skin of body—systemic scleroderma	0.00243	0.0228	CbGeAlD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL13—systemic scleroderma	0.00238	0.026	CbGpPWpGaD
Gallium nitrate—BGLAP—connective tissue—systemic scleroderma	0.00231	0.0216	CbGeAlD
Gallium nitrate—IL1B—IL27-mediated signaling events—STAT4—systemic scleroderma	0.00229	0.025	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—AIF1—systemic scleroderma	0.00223	0.0244	CbGpPWpGaD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—CSF1—systemic scleroderma	0.00223	0.0243	CbGpPWpGaD
Gallium nitrate—IL1B—connective tissue—systemic scleroderma	0.00197	0.0184	CbGeAlD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—IRF8—systemic scleroderma	0.00196	0.0214	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—digestive system—systemic scleroderma	0.00195	0.0182	CbGeAlD
Gallium nitrate—ATP6V1B2—tendon—systemic scleroderma	0.00185	0.0173	CbGeAlD
Gallium nitrate—IL1B—smooth muscle tissue—systemic scleroderma	0.0018	0.0169	CbGeAlD
Gallium nitrate—ATP6V1B2—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—systemic scleroderma	0.0018	0.0196	CbGpPWpGaD
Gallium nitrate—IL1B—skin of body—systemic scleroderma	0.00178	0.0167	CbGeAlD
Gallium nitrate—TF—connective tissue—systemic scleroderma	0.00176	0.0165	CbGeAlD
Gallium nitrate—IL1B—IL23-mediated signaling events—STAT4—systemic scleroderma	0.00173	0.0189	CbGpPWpGaD
Gallium nitrate—TF—Platelet degranulation—SELP—systemic scleroderma	0.00171	0.0187	CbGpPWpGaD
Gallium nitrate—Lung infiltration—Lisinopril—systemic scleroderma	0.00171	0.0237	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.00163	0.0178	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—lung—systemic scleroderma	0.00163	0.0152	CbGeAlD
Gallium nitrate—Hypophosphataemia—Leflunomide—systemic scleroderma	0.0016	0.0223	CcSEcCtD
Gallium nitrate—TF—skin of body—systemic scleroderma	0.00159	0.0149	CbGeAlD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.00158	0.0172	CbGpPWpGaD
Gallium nitrate—RRM2—skin of body—systemic scleroderma	0.00157	0.0147	CbGeAlD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—IL13—systemic scleroderma	0.00157	0.0171	CbGpPWpGaD
Gallium nitrate—Hypophosphataemia—Mycophenolic acid—systemic scleroderma	0.00153	0.0213	CcSEcCtD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL1A—systemic scleroderma	0.0015	0.0164	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—CSF1—systemic scleroderma	0.00149	0.0163	CbGpPWpGaD
Gallium nitrate—Blindness—Lisinopril—systemic scleroderma	0.00145	0.0201	CcSEcCtD
Gallium nitrate—IL1B—digestive system—systemic scleroderma	0.00142	0.0133	CbGeAlD
Gallium nitrate—IL1B—tendon—systemic scleroderma	0.00136	0.0127	CbGeAlD
Gallium nitrate—IL1B—IL12-mediated signaling events—CD247—systemic scleroderma	0.00133	0.0146	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.00128	0.014	CbGpPWpGaD
Gallium nitrate—TF—digestive system—systemic scleroderma	0.00127	0.0119	CbGeAlD
Gallium nitrate—RRM2—digestive system—systemic scleroderma	0.00125	0.0117	CbGeAlD
Gallium nitrate—IL1B—IL1-mediated signaling events—IL1A—systemic scleroderma	0.00125	0.0136	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.00122	0.0133	CbGpPWpGaD
Gallium nitrate—Hypophosphataemia—Mycophenolate mofetil—systemic scleroderma	0.00121	0.0168	CcSEcCtD
Gallium nitrate—RRM2—tendon—systemic scleroderma	0.00119	0.0112	CbGeAlD
Gallium nitrate—IL1B—lung—systemic scleroderma	0.00119	0.0111	CbGeAlD
Gallium nitrate—IL1B—IL12-mediated signaling events—STAT4—systemic scleroderma	0.00117	0.0128	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Mycophenolic acid—systemic scleroderma	0.00116	0.0161	CcSEcCtD
Gallium nitrate—IL1B—Methylprednisolone—Mometasone—systemic scleroderma	0.00116	0.255	CbGdCrCtD
Gallium nitrate—Neoplasm malignant—Azathioprine—systemic scleroderma	0.00116	0.0161	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.00114	0.0125	CbGpPWpGaD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—CCL2—systemic scleroderma	0.00113	0.0124	CbGpPWpGaD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—IL1A—systemic scleroderma	0.00109	0.0119	CbGpPWpGaD
Gallium nitrate—IL1B—Interleukin-1 signaling—IL1A—systemic scleroderma	0.00109	0.0119	CbGpPWpGaD
Gallium nitrate—Encephalopathy—Mycophenolate mofetil—systemic scleroderma	0.00109	0.0152	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.00109	0.0119	CbGpPWpGaD
Gallium nitrate—TF—lung—systemic scleroderma	0.00106	0.00992	CbGeAlD
Gallium nitrate—RRM2—lung—systemic scleroderma	0.00105	0.0098	CbGeAlD
Gallium nitrate—Pleural effusion—Lisinopril—systemic scleroderma	0.00105	0.0145	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Mycophenolic acid—systemic scleroderma	0.00104	0.0145	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—IL13—systemic scleroderma	0.00101	0.011	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—SELP—systemic scleroderma	0.000972	0.0106	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Mycophenolic acid—systemic scleroderma	0.000971	0.0135	CcSEcCtD
Gallium nitrate—Rales—Methotrexate—systemic scleroderma	0.000969	0.0135	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—CD247—systemic scleroderma	0.000965	0.0105	CbGpPWpGaD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000951	0.0104	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000916	0.01	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Mycophenolate mofetil—systemic scleroderma	0.000916	0.0127	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000913	0.00997	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—RHOB—systemic scleroderma	0.000907	0.0099	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IRF5—systemic scleroderma	0.000892	0.00974	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Captopril—systemic scleroderma	0.000889	0.0124	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—IL1A—systemic scleroderma	0.000848	0.00926	CbGpPWpGaD
Gallium nitrate—Lung infiltration—Methotrexate—systemic scleroderma	0.000847	0.0118	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.000833	0.0091	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—CTLA4—systemic scleroderma	0.000812	0.00886	CbGpPWpGaD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—MMP9—systemic scleroderma	0.00081	0.00884	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000801	0.00874	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Prednisone—systemic scleroderma	0.000773	0.0107	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Mycophenolate mofetil—systemic scleroderma	0.000766	0.0107	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000759	0.00828	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000755	0.00824	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Mometasone—systemic scleroderma	0.000717	0.158	CbGdCrCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000713	0.00778	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000708	0.00773	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Mycophenolic acid—systemic scleroderma	0.000699	0.00972	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—MMP9—systemic scleroderma	0.000677	0.00739	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000668	0.0073	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	0.000657	0.00718	CbGpPWpGaD
Gallium nitrate—Erythema—Pentoxifylline—systemic scleroderma	0.000652	0.00907	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000645	0.00704	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000638	0.00697	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL1A—systemic scleroderma	0.000635	0.00693	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—CD40LG—systemic scleroderma	0.000631	0.00689	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Prednisone—systemic scleroderma	0.000631	0.139	CbGdCrCtD
Gallium nitrate—Renal failure acute—Lisinopril—systemic scleroderma	0.000629	0.00875	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—TGFB1—systemic scleroderma	0.000626	0.00683	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000619	0.00676	CbGpPWpGaD
Gallium nitrate—Encephalopathy—Methotrexate—systemic scleroderma	0.000619	0.00861	CcSEcCtD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TGFB1—systemic scleroderma	0.000607	0.00663	CbGpPWpGaD
Gallium nitrate—Anaemia—Pentoxifylline—systemic scleroderma	0.000603	0.00838	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000585	0.00639	CbGpPWpGaD
Gallium nitrate—Leukopenia—Pentoxifylline—systemic scleroderma	0.000584	0.00811	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000583	0.00637	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000572	0.00624	CbGpPWpGaD
Gallium nitrate—Hallucination—Captopril—systemic scleroderma	0.000565	0.00785	CcSEcCtD
Gallium nitrate—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00767	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.000541	0.00591	CbGpPWpGaD
Gallium nitrate—Confusional state—Pentoxifylline—systemic scleroderma	0.000537	0.00746	CcSEcCtD
Gallium nitrate—Tachycardia—Pentoxifylline—systemic scleroderma	0.000519	0.00722	CcSEcCtD
Gallium nitrate—Pleural effusion—Methotrexate—systemic scleroderma	0.000519	0.00721	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IL1A—systemic scleroderma	0.000506	0.00552	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—CCL2—systemic scleroderma	0.000504	0.0055	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL1A—systemic scleroderma	0.000494	0.0054	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—TGFB1—systemic scleroderma	0.000494	0.0054	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CENPC—systemic scleroderma	0.000484	0.00528	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Mometasone—systemic scleroderma	0.000479	0.105	CbGdCrCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000475	0.00519	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000474	0.0066	CcSEcCtD
Gallium nitrate—Oedema peripheral—Leflunomide—systemic scleroderma	0.000461	0.00641	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—IL1A—systemic scleroderma	0.000461	0.00503	CbGpPWpGaD
Gallium nitrate—Anaemia—Captopril—systemic scleroderma	0.000457	0.00635	CcSEcCtD
Gallium nitrate—Constipation—Pentoxifylline—systemic scleroderma	0.000455	0.00633	CcSEcCtD
Gallium nitrate—Hallucination—Mycophenolic acid—systemic scleroderma	0.000444	0.00617	CcSEcCtD
Gallium nitrate—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00044	0.00611	CcSEcCtD
Gallium nitrate—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000439	0.0061	CcSEcCtD
Gallium nitrate—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000421	0.00585	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—SMAD7—systemic scleroderma	0.000417	0.00455	CbGpPWpGaD
Gallium nitrate—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000416	0.00579	CcSEcCtD
Gallium nitrate—Paraesthesia—Mometasone—systemic scleroderma	0.000412	0.00573	CcSEcCtD
Gallium nitrate—Dyspnoea—Mometasone—systemic scleroderma	0.000409	0.00569	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000407	0.00445	CbGpPWpGaD
Gallium nitrate—Confusional state—Captopril—systemic scleroderma	0.000407	0.00565	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—NOS3—systemic scleroderma	0.000406	0.00443	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.0004	0.00437	CbGpPWpGaD
Gallium nitrate—Hallucination—Lisinopril—systemic scleroderma	0.0004	0.00556	CcSEcCtD
Gallium nitrate—Anaemia—Azathioprine—systemic scleroderma	0.000399	0.00554	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000397	0.00433	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Lisinopril—systemic scleroderma	0.000396	0.00551	CcSEcCtD
Gallium nitrate—Tachycardia—Captopril—systemic scleroderma	0.000394	0.00547	CcSEcCtD
Gallium nitrate—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000392	0.00545	CcSEcCtD
Gallium nitrate—TF—Hemostasis—SELP—systemic scleroderma	0.000391	0.00427	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Prednisone—systemic scleroderma	0.000391	0.0861	CbGdCrCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.000389	0.00425	CbGpPWpGaD
Gallium nitrate—Leukopenia—Azathioprine—systemic scleroderma	0.000386	0.00537	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—TGFBI—systemic scleroderma	0.000381	0.00416	CbGpPWpGaD
Gallium nitrate—Pruritus—Pentoxifylline—systemic scleroderma	0.000377	0.00523	CcSEcCtD
Gallium nitrate—Anaemia—Leflunomide—systemic scleroderma	0.000376	0.00523	CcSEcCtD
Gallium nitrate—Tinnitus—Lisinopril—systemic scleroderma	0.000375	0.00521	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000368	0.00402	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—RHOB—systemic scleroderma	0.000365	0.00399	CbGpPWpGaD
Gallium nitrate—Leukopenia—Leflunomide—systemic scleroderma	0.000365	0.00507	CcSEcCtD
Gallium nitrate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000364	0.00506	CcSEcCtD
Gallium nitrate—Coma—Methotrexate—systemic scleroderma	0.000363	0.00505	CcSEcCtD
Gallium nitrate—Body temperature increased—Mometasone—systemic scleroderma	0.000363	0.00505	CcSEcCtD
Gallium nitrate—Paraesthesia—Captopril—systemic scleroderma	0.000362	0.00503	CcSEcCtD
Gallium nitrate—Dyspnoea—Captopril—systemic scleroderma	0.00036	0.005	CcSEcCtD
Gallium nitrate—Anaemia—Mycophenolic acid—systemic scleroderma	0.000359	0.00499	CcSEcCtD
Gallium nitrate—Lethargy—Prednisone—systemic scleroderma	0.000352	0.0049	CcSEcCtD
Gallium nitrate—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00035	0.00487	CcSEcCtD
Gallium nitrate—Erythema—Lisinopril—systemic scleroderma	0.00035	0.00487	CcSEcCtD
Gallium nitrate—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000348	0.00484	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.000347	0.00379	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000347	0.00482	CcSEcCtD
Gallium nitrate—Constipation—Captopril—systemic scleroderma	0.000345	0.00479	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000344	0.00375	CbGpPWpGaD
Gallium nitrate—Vomiting—Pentoxifylline—systemic scleroderma	0.000338	0.0047	CcSEcCtD
Gallium nitrate—Rash—Pentoxifylline—systemic scleroderma	0.000336	0.00467	CcSEcCtD
Gallium nitrate—Dermatitis—Pentoxifylline—systemic scleroderma	0.000335	0.00466	CcSEcCtD
Gallium nitrate—TF—Hemostasis—CSK—systemic scleroderma	0.000333	0.00363	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Captopril—systemic scleroderma	0.000332	0.00462	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—TGFB1—systemic scleroderma	0.000328	0.00359	CbGpPWpGaD
Gallium nitrate—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00457	CcSEcCtD
Gallium nitrate—Pruritus—Mometasone—systemic scleroderma	0.000325	0.00452	CcSEcCtD
Gallium nitrate—Tachycardia—Leflunomide—systemic scleroderma	0.000324	0.00451	CcSEcCtD
Gallium nitrate—Anaemia—Lisinopril—systemic scleroderma	0.000323	0.0045	CcSEcCtD
Gallium nitrate—Confusional state—Mycophenolic acid—systemic scleroderma	0.00032	0.00445	CcSEcCtD
Gallium nitrate—Body temperature increased—Captopril—systemic scleroderma	0.000319	0.00443	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—CCL2—systemic scleroderma	0.000317	0.00346	CbGpPWpGaD
Gallium nitrate—Nausea—Pentoxifylline—systemic scleroderma	0.000316	0.00439	CcSEcCtD
Gallium nitrate—Diarrhoea—Mometasone—systemic scleroderma	0.000314	0.00437	CcSEcCtD
Gallium nitrate—Leukopenia—Lisinopril—systemic scleroderma	0.000313	0.00436	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000313	0.00342	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—ITGAM—systemic scleroderma	0.000313	0.00341	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Methotrexate—systemic scleroderma	0.000312	0.00434	CcSEcCtD
Gallium nitrate—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000309	0.0043	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—CENPA—systemic scleroderma	0.000307	0.00336	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HSPG2—systemic scleroderma	0.000304	0.00332	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Leflunomide—systemic scleroderma	0.000298	0.00415	CcSEcCtD
Gallium nitrate—Dyspnoea—Leflunomide—systemic scleroderma	0.000296	0.00412	CcSEcCtD
Gallium nitrate—Lethargy—Methotrexate—systemic scleroderma	0.000294	0.00409	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—CSK—systemic scleroderma	0.000294	0.00321	CbGpPWpGaD
Gallium nitrate—IL1B—Betamethasone—Mometasone—systemic scleroderma	0.000293	0.0645	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Mometasone—systemic scleroderma	0.000293	0.0645	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SMAD7—systemic scleroderma	0.000292	0.00319	CbGpPWpGaD
Gallium nitrate—Vomiting—Mometasone—systemic scleroderma	0.000292	0.00406	CcSEcCtD
Gallium nitrate—Feeling abnormal—Azathioprine—systemic scleroderma	0.00029	0.00403	CcSEcCtD
Gallium nitrate—Rash—Mometasone—systemic scleroderma	0.00029	0.00403	CcSEcCtD
Gallium nitrate—Dermatitis—Mometasone—systemic scleroderma	0.000289	0.00402	CcSEcCtD
Gallium nitrate—Confusional state—Lisinopril—systemic scleroderma	0.000288	0.004	CcSEcCtD
Gallium nitrate—Pruritus—Captopril—systemic scleroderma	0.000285	0.00397	CcSEcCtD
Gallium nitrate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000285	0.00396	CcSEcCtD
Gallium nitrate—Constipation—Leflunomide—systemic scleroderma	0.000284	0.00395	CcSEcCtD
Gallium nitrate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00394	CcSEcCtD
Gallium nitrate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000283	0.00393	CcSEcCtD
Gallium nitrate—Tachycardia—Lisinopril—systemic scleroderma	0.000279	0.00388	CcSEcCtD
Gallium nitrate—Body temperature increased—Azathioprine—systemic scleroderma	0.000278	0.00387	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—CD247—systemic scleroderma	0.000276	0.00302	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Captopril—systemic scleroderma	0.000276	0.00384	CcSEcCtD
Gallium nitrate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00382	CcSEcCtD
Gallium nitrate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000274	0.00381	CcSEcCtD
Gallium nitrate—Nausea—Mometasone—systemic scleroderma	0.000273	0.00379	CcSEcCtD
Gallium nitrate—Constipation—Mycophenolic acid—systemic scleroderma	0.000271	0.00377	CcSEcCtD
Gallium nitrate—Body temperature increased—Leflunomide—systemic scleroderma	0.000263	0.00365	CcSEcCtD
Gallium nitrate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000261	0.00363	CcSEcCtD
Gallium nitrate—IL1B—Budesonide—Prednisone—systemic scleroderma	0.000261	0.0575	CbGdCrCtD
Gallium nitrate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000259	0.00361	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—TGFB1—systemic scleroderma	0.000257	0.00281	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Lisinopril—systemic scleroderma	0.000256	0.00357	CcSEcCtD
Gallium nitrate—Vomiting—Captopril—systemic scleroderma	0.000256	0.00357	CcSEcCtD
Gallium nitrate—Dyspnoea—Lisinopril—systemic scleroderma	0.000255	0.00354	CcSEcCtD
Gallium nitrate—Rash—Captopril—systemic scleroderma	0.000254	0.00354	CcSEcCtD
Gallium nitrate—Dermatitis—Captopril—systemic scleroderma	0.000254	0.00353	CcSEcCtD
Gallium nitrate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00351	CcSEcCtD
Gallium nitrate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000251	0.00349	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000248	0.0027	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000245	0.0034	CcSEcCtD
Gallium nitrate—Constipation—Lisinopril—systemic scleroderma	0.000244	0.0034	CcSEcCtD
Gallium nitrate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000244	0.0034	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000243	0.00265	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Azathioprine—systemic scleroderma	0.000241	0.00335	CcSEcCtD
Gallium nitrate—Nausea—Captopril—systemic scleroderma	0.00024	0.00333	CcSEcCtD
Gallium nitrate—Hallucination—Prednisone—systemic scleroderma	0.000238	0.0033	CcSEcCtD
Gallium nitrate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000235	0.00327	CcSEcCtD
Gallium nitrate—Pruritus—Leflunomide—systemic scleroderma	0.000235	0.00327	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—TGFB1—systemic scleroderma	0.000232	0.00253	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000231	0.00252	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Leflunomide—systemic scleroderma	0.000227	0.00316	CcSEcCtD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000227	0.00248	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MMP9—systemic scleroderma	0.000226	0.00247	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RHOB—systemic scleroderma	0.000226	0.00247	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Lisinopril—systemic scleroderma	0.000226	0.00314	CcSEcCtD
Gallium nitrate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000225	0.00312	CcSEcCtD
Gallium nitrate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000224	0.00312	CcSEcCtD
Gallium nitrate—Vomiting—Azathioprine—systemic scleroderma	0.000224	0.00311	CcSEcCtD
Gallium nitrate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000223	0.0031	CcSEcCtD
Gallium nitrate—Rash—Azathioprine—systemic scleroderma	0.000222	0.00309	CcSEcCtD
Gallium nitrate—Dermatitis—Azathioprine—systemic scleroderma	0.000222	0.00308	CcSEcCtD
Gallium nitrate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000217	0.00302	CcSEcCtD
Gallium nitrate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000214	0.00298	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HSPG2—systemic scleroderma	0.000213	0.00233	CbGpPWpGaD
Gallium nitrate—Vomiting—Leflunomide—systemic scleroderma	0.000211	0.00294	CcSEcCtD
Gallium nitrate—Hypersensitivity—Lisinopril—systemic scleroderma	0.00021	0.00293	CcSEcCtD
Gallium nitrate—Rash—Leflunomide—systemic scleroderma	0.00021	0.00291	CcSEcCtD
Gallium nitrate—Dermatitis—Leflunomide—systemic scleroderma	0.000209	0.00291	CcSEcCtD
Gallium nitrate—Nausea—Azathioprine—systemic scleroderma	0.000209	0.00291	CcSEcCtD
Gallium nitrate—Erythema—Prednisone—systemic scleroderma	0.000208	0.00289	CcSEcCtD
Gallium nitrate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00287	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CSK—systemic scleroderma	0.000206	0.00225	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	0.000205	0.00224	CbGpPWpGaD
Gallium nitrate—Pruritus—Lisinopril—systemic scleroderma	0.000202	0.00281	CcSEcCtD
Gallium nitrate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000202	0.0028	CcSEcCtD
Gallium nitrate—Rash—Mycophenolic acid—systemic scleroderma	0.0002	0.00278	CcSEcCtD
Gallium nitrate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0002	0.00278	CcSEcCtD
Gallium nitrate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00275	CcSEcCtD
Gallium nitrate—Nausea—Leflunomide—systemic scleroderma	0.000197	0.00275	CcSEcCtD
Gallium nitrate—Diarrhoea—Lisinopril—systemic scleroderma	0.000195	0.00272	CcSEcCtD
Gallium nitrate—Anaemia—Prednisone—systemic scleroderma	0.000192	0.00267	CcSEcCtD
Gallium nitrate—Nausea—Mycophenolic acid—systemic scleroderma	0.000188	0.00262	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—TGFB1—systemic scleroderma	0.000187	0.00204	CbGpPWpGaD
Gallium nitrate—Tinnitus—Methotrexate—systemic scleroderma	0.000186	0.00259	CcSEcCtD
Gallium nitrate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000184	0.00256	CcSEcCtD
Gallium nitrate—Vomiting—Lisinopril—systemic scleroderma	0.000182	0.00252	CcSEcCtD
Gallium nitrate—Rash—Lisinopril—systemic scleroderma	0.00018	0.0025	CcSEcCtD
Gallium nitrate—Dermatitis—Lisinopril—systemic scleroderma	0.00018	0.0025	CcSEcCtD
Gallium nitrate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000177	0.00246	CcSEcCtD
Gallium nitrate—Erythema—Methotrexate—systemic scleroderma	0.000174	0.00242	CcSEcCtD
Gallium nitrate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00238	CcSEcCtD
Gallium nitrate—Nausea—Lisinopril—systemic scleroderma	0.00017	0.00236	CcSEcCtD
Gallium nitrate—Tachycardia—Prednisone—systemic scleroderma	0.000166	0.0023	CcSEcCtD
Gallium nitrate—Anaemia—Methotrexate—systemic scleroderma	0.000161	0.00223	CcSEcCtD
Gallium nitrate—IL1B—Betamethasone—Prednisone—systemic scleroderma	0.00016	0.0352	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Prednisone—systemic scleroderma	0.00016	0.0352	CbGdCrCtD
Gallium nitrate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00221	CcSEcCtD
Gallium nitrate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00219	CcSEcCtD
Gallium nitrate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00219	CcSEcCtD
Gallium nitrate—TF—Hemostasis—MMP1—systemic scleroderma	0.000157	0.00171	CbGpPWpGaD
Gallium nitrate—Leukopenia—Methotrexate—systemic scleroderma	0.000155	0.00216	CcSEcCtD
Gallium nitrate—Paraesthesia—Prednisone—systemic scleroderma	0.000152	0.00212	CcSEcCtD
Gallium nitrate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000149	0.00207	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000146	0.00159	CbGpPWpGaD
Gallium nitrate—Constipation—Prednisone—systemic scleroderma	0.000145	0.00202	CcSEcCtD
Gallium nitrate—Confusional state—Methotrexate—systemic scleroderma	0.000143	0.00199	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TGFB1—systemic scleroderma	0.000141	0.00154	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Prednisone—systemic scleroderma	0.00014	0.00194	CcSEcCtD
Gallium nitrate—IL1B—Immune System—CSK—systemic scleroderma	0.000135	0.00148	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Prednisone—systemic scleroderma	0.000134	0.00186	CcSEcCtD
Gallium nitrate—IL1B—Immune System—IRF5—systemic scleroderma	0.000133	0.00145	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Methotrexate—systemic scleroderma	0.000127	0.00177	CcSEcCtD
Gallium nitrate—IL1B—Immune System—ITGAM—systemic scleroderma	0.000127	0.00139	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IRF8—systemic scleroderma	0.000127	0.00139	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD247—systemic scleroderma	0.000127	0.00139	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Methotrexate—systemic scleroderma	0.000126	0.00176	CcSEcCtD
Gallium nitrate—Hypersensitivity—Prednisone—systemic scleroderma	0.000125	0.00174	CcSEcCtD
Gallium nitrate—Pruritus—Prednisone—systemic scleroderma	0.00012	0.00167	CcSEcCtD
Gallium nitrate—IL1B—Immune System—TNFAIP3—systemic scleroderma	0.000119	0.0013	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—BLK—systemic scleroderma	0.000118	0.00128	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000117	0.00162	CcSEcCtD
Gallium nitrate—Diarrhoea—Prednisone—systemic scleroderma	0.000116	0.00161	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—EDN1—systemic scleroderma	0.000115	0.00126	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—NOS3—systemic scleroderma	0.000114	0.00124	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Methotrexate—systemic scleroderma	0.000112	0.00156	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—HSPG2—systemic scleroderma	0.00011	0.0012	CbGpPWpGaD
Gallium nitrate—Vomiting—Prednisone—systemic scleroderma	0.000108	0.0015	CcSEcCtD
Gallium nitrate—Rash—Prednisone—systemic scleroderma	0.000107	0.00149	CcSEcCtD
Gallium nitrate—Dermatitis—Prednisone—systemic scleroderma	0.000107	0.00149	CcSEcCtD
Gallium nitrate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000104	0.00145	CcSEcCtD
Gallium nitrate—Nausea—Prednisone—systemic scleroderma	0.000101	0.0014	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—NOS3—systemic scleroderma	0.0001	0.0011	CbGpPWpGaD
Gallium nitrate—Pruritus—Methotrexate—systemic scleroderma	0.0001	0.00139	CcSEcCtD
Gallium nitrate—Diarrhoea—Methotrexate—systemic scleroderma	9.7e-05	0.00135	CcSEcCtD
Gallium nitrate—IL1B—Immune System—CTLA4—systemic scleroderma	9.63e-05	0.00105	CbGpPWpGaD
Gallium nitrate—Vomiting—Methotrexate—systemic scleroderma	9.01e-05	0.00125	CcSEcCtD
Gallium nitrate—Rash—Methotrexate—systemic scleroderma	8.94e-05	0.00124	CcSEcCtD
Gallium nitrate—Dermatitis—Methotrexate—systemic scleroderma	8.93e-05	0.00124	CcSEcCtD
Gallium nitrate—Nausea—Methotrexate—systemic scleroderma	8.42e-05	0.00117	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—CTGF—systemic scleroderma	8.35e-05	0.000912	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-DQB1—systemic scleroderma	7.93e-05	0.000866	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CCL2—systemic scleroderma	7.88e-05	0.000861	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL1A—systemic scleroderma	7.53e-05	0.000823	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TGFB1—systemic scleroderma	7.51e-05	0.00082	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD40LG—systemic scleroderma	7.49e-05	0.000818	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NOS3—systemic scleroderma	7.03e-05	0.000767	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—TGFB1—systemic scleroderma	6.64e-05	0.000724	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MMP9—systemic scleroderma	5.64e-05	0.000615	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TGFB1—systemic scleroderma	4.65e-05	0.000507	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NOS3—systemic scleroderma	3.64e-05	0.000397	CbGpPWpGaD
